HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 262 filers reported holding HAEMONETICS CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,288,000 | -53.2% | 37,688 | -46.5% | 0.96% | +31.2% |
| Q1 2020 | $7,022,000 | +254.6% | 70,464 | +307.8% | 0.73% | +416.9% |
| Q3 2018 | $1,980,000 | +25.6% | 17,278 | -1.8% | 0.14% | +24.6% |
| Q2 2018 | $1,577,000 | +22.5% | 17,586 | 0.0% | 0.11% | +17.5% |
| Q1 2018 | $1,287,000 | -89.7% | 17,586 | -91.8% | 0.10% | -89.5% |
| Q4 2017 | $12,531,000 | +911.4% | 215,757 | +681.2% | 0.92% | +995.2% |
| Q3 2017 | $1,239,000 | -79.0% | 27,619 | -81.1% | 0.08% | -79.3% |
| Q4 2016 | $5,888,000 | -33.0% | 146,483 | -39.6% | 0.41% | -35.9% |
| Q3 2016 | $8,784,000 | -13.6% | 242,592 | -30.8% | 0.63% | -10.1% |
| Q2 2016 | $10,162,000 | +63.7% | 350,563 | +97.5% | 0.70% | +70.0% |
| Q1 2016 | $6,209,000 | +233.8% | 177,525 | +207.7% | 0.41% | +209.0% |
| Q4 2015 | $1,860,000 | – | 57,703 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |